Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KOD Kodiak Sciences > Company Profile
KOD Kodiak Sciences
7.540
+0.150+2.03%
Post Mkt Price
7.510
-0.030-0.40%
Symbol
KOD
Company Name
Kodiak Sciences
Listing Date
10/04/2018
Establishment Date
2009
CEO
Dr. Victor Perlroth, M.D.
Market
NASDAQ
Employees
93
Securities Type
DR
Fiscal Year Ends
12-31
Address
1200 Page Mill Road
City
Palo Alto
Province
California
Country
United States of America
Zip code
94304
Phone
1-650-281-0850
Profile
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Company Overview
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
CEO: Dr. Victor Perlroth, M.D.
Market: NASDAQ
Listing Date: 10/04/2018
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist